On Air Now

Current Show

America Now with Andy Dean   8:00 PM - 11:00 PM

Call America Now at 877-927-2639 between 5pm and 8pm

Show Info »

Upcoming Shows

Program Schedule »

Listen

Listen Live Now » 550 AM Wausau, WI 99.9 FM Stevens Point, WI

Weather

Current Conditions(Wausau,WI 54403)

More Weather »
69° Feels Like: 69°
Wind: W 6 mph Past 24 hrs - Precip: 0.04”
Current Radar for Zip

Tonight

Mostly Clear 56°

Tomorrow

Scattered Thunderstorms 80°

Sat Night

Mostly Clear 55°

Alerts

Dynavax withdraws EU marketing application for Hep B vaccine

(Reuters) - Dynavax Technologies Corp said it had withdrawn a European marketing application for its experimental hepatitis B vaccine due to safety concerns raised by the European Medicines Agency.

The EMA had said current safety data on the vaccine, Heplisav, was too limited to rule out a risk of "less common serious adverse events.

Heplisav is the company's most advanced produced under development.

The drug developer said it withdrew the application because it would not be able to gather sufficient data to respond to the regulator in the time required.

An additional 8,000-subject trial intended to provide the data is expected to begin soon, the company said.

Berkeley, California-based Dynavax suffered a similar setback in February last year when the U.S. Food and Drug Administration rejected the vaccine.

Dynavax's shares, which fell about 3 percent in early trading, were up 1.7 percent at $1.79 on the Nasdaq.

(Reporting by Natalie Grover in Bangalore; Editing by Ted Kerr)

Comments